Our research group and others have identified in ECs an important role for fibro-inflammatory pathways in PAD pathology related to thrombospondin-1 (THBS1) and cellular communication network factor 2 (CCN2), previously better known as connective tissue growth factor (9, 13). This evidence concerns the gene CCN2 and peripheral arterial disease.